Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,200 shares at $752.19 ($1.7M) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Open-market sale of $1.7M REGN by EVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $752.19 | 1,100 | $827K | 50.0% |
| 2 | $752.19 | 1,100 | $827K | 50.0% |
| Total | $752.19 avg | 2,200 | $1.7M | 100% |
| Filing → |
| REGN | SELL | 2024-11-05 | $845K | — | Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |